documents: FDA-2009-N-0493-0004
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-N-0493-0004 | FDA | FDA-2009-N-0493 | Tab B - "Substantive Changes and Changes in the Regulatory Action, May 3, 2010" - [OMB Review, Executive Order 12866, Regulatory Policy Management Staff to the Division of Dockets Management, (Neurological and Physical Medicine Devices; Designation of Special Controls for Certain Class II Devices and Exemption From Premarket Notification, Proposed Rule, April 5, 2010)] | Supporting & Related Material | REF-Reference (internal unless indicated) | 2010-05-05T04:00:00Z | 2010 | 5 | 2011-06-11T16:28:07Z | 0 | 0 | 0900006480ae6fff |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref